These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
524 related articles for article (PubMed ID: 19309338)
1. Photodynamic therapy for the treatment of cutaneous neoplasia, inflammatory disorders, and photoaging. Tierney E; Barker A; Ahdout J; Hanke CW; Moy RL; Kouba DJ Dermatol Surg; 2009 May; 35(5):725-46. PubMed ID: 19309338 [TBL] [Abstract][Full Text] [Related]
2. Photodynamic therapy in dermatology: current concepts in the treatment of skin cancer. Garcia-Zuazaga J; Cooper KD; Baron ED Expert Rev Anticancer Ther; 2005 Oct; 5(5):791-800. PubMed ID: 16221049 [TBL] [Abstract][Full Text] [Related]
4. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503 [TBL] [Abstract][Full Text] [Related]
5. [Photodynamic therapy: new indications]. Fernández-Guarino M; García-Morales I; Harto A; Montull C; Pérez-García B; Jaén P Actas Dermosifiliogr; 2007; 98(6):377-95. PubMed ID: 17663928 [TBL] [Abstract][Full Text] [Related]
6. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Itkin A; Gilchrest BA Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801 [TBL] [Abstract][Full Text] [Related]
7. Current treatments of actinic keratosis. Gold MH; Nestor MS J Drugs Dermatol; 2006 Feb; 5(2 Suppl):17-25. PubMed ID: 16485877 [TBL] [Abstract][Full Text] [Related]
11. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma. Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077 [TBL] [Abstract][Full Text] [Related]
12. Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Dragieva G; Hafner J; Dummer R; Schmid-Grendelmeier P; Roos M; Prinz BM; Burg G; Binswanger U; Kempf W Transplantation; 2004 Jan; 77(1):115-21. PubMed ID: 14724445 [TBL] [Abstract][Full Text] [Related]
13. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606 [TBL] [Abstract][Full Text] [Related]
14. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Gold MH; Bradshaw VL; Boring MM; Bridges TM; Biron JA Dermatol Surg; 2006 Jun; 32(6):795-801; discussion 801-3. PubMed ID: 16792644 [TBL] [Abstract][Full Text] [Related]
15. An open pilot study of ambulatory photodynamic therapy using a wearable low-irradiance organic light-emitting diode light source in the treatment of nonmelanoma skin cancer. Attili SK; Lesar A; McNeill A; Camacho-Lopez M; Moseley H; Ibbotson S; Samuel ID; Ferguson J Br J Dermatol; 2009 Jul; 161(1):170-3. PubMed ID: 19302071 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic Hotline: Facial skin rejuvenation in a patient treated with photodynamic therapy for actinic keratosis. Bruscino N; Rossi R; Dindelli M; Ghersetich I; Lotti T Dermatol Ther; 2010; 23(1):86-9. PubMed ID: 20136912 [TBL] [Abstract][Full Text] [Related]
18. 5-aminolevulinic acid photodynamic therapy: where we have been and where we are going. Gold MH; Goldman MP Dermatol Surg; 2004 Aug; 30(8):1077-83; discussion 1083-4. PubMed ID: 15274696 [TBL] [Abstract][Full Text] [Related]
19. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? Morton CA J Dermatolog Treat; 2002; 13 Suppl 1():S25-9. PubMed ID: 12060514 [TBL] [Abstract][Full Text] [Related]